{"transactions":[{"id":1100704,"issuer":{"id":1465,"kind":"organization","name":"NATURES SUNSHINE PRODUCTS INC","symbol":"NATR"},"owners":[{"id":78075,"kind":"organization","name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","position":1,"cik":"0001615258","reported_name":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd.","relationship":{"ten_percent_owner":true}},{"id":78076,"kind":"organization","name":"Fosun Pharma USA Inc.","position":2,"cik":"0002071437","reported_name":"Fosun Pharma USA Inc.","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-06-27T20:27:23.000Z","date":"2025-06-27","kind":"sale","planned":false,"acquired":false,"shares":2854607,"price":11.46,"value":32713796.22,"ownership":{"direct":false,"nature":"by Fosun Pharma USA Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to that certain Underwriting Agreement. dated June 25, 2025, among Fosun Pharma USA Inc., the Issuer, and the underwriter party thereto."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Fosun Pharma USA Inc. is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-25-023976","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/275053/000114036125023976/form4.xml","form_type":"4"}}]}